Biomerica (BMRA) Non-Current Deferred Tax Liability (2016 - 2017)
Biomerica (BMRA) posted Non-Current Deferred Tax Liability of $8000.0 for Q2 2017, down 84.91% sequentially from $53000.0 in Q2 2016, and down 84.91% YoY from $53000.0 in Q2 2016.
Biomerica (BMRA) Non-Current Deferred Tax Liability (2016 - 2017) Analysis & Trends
Biomerica has reported Non-Current Deferred Tax Liability for 2 years, with the latest figure at $8000.0 in Q2 2017.
- Quarterly Non-Current Deferred Tax Liability fell 84.91% year-over-year to $8000.0 in Q2 2017, while the trailing twelve-month figure through May 2017 was $8000.0 (down 84.91% YoY) and the FY2017 annual result came in at $8000.0, down 84.91% from the prior year.
- Non-Current Deferred Tax Liability eased to $8000.0 in Q2 2017 per BMRA's latest filing, from $53000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $53000.0 in Q2 2016 and troughed at $8000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2017 | 8,000.00 |
| May 31, 2017 | 8,000.00 |
| May 31, 2016 | 53,000.00 |
| May 31, 2016 | 53,000.00 |